Facilitating Antibacterial Drug Development in a Time of Great Need
The continued development of new antibacterial drugs is critical to meet patient and public health needs. In this editorial, authors from the US Food and Drug Administration and European Medicines Agency reflect on the role of public–private partnerships and the development of clinical trials networ...
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 2016-08, Vol.63 (suppl 2), p.S27-S28 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The continued development of new antibacterial drugs is critical to meet patient and public health needs. In this editorial, authors from the US Food and Drug Administration and European Medicines Agency reflect on the role of public–private partnerships and the development of clinical trials networks as agents to guide and perform quality studies of antibacterial drugs. |
---|---|
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1093/cid/ciw257 |